Cost of Oncology Drugs in the Middle-Eastern Country of Lebanon: An Update (2014-2016)
Purpose: This study aims to evaluate trends in the increasing costs of oncology drugs procured by the Lebanese Ministry of Public Health (MOPH) between 2014 and 2016 and to assess the impact of the introduction in mid-2015 of new immunotherapy drugs for the treatment of lung cancer on the overall an...
Main Authors: | Fadia Elias, Ibrahim R. Bou-Orm, Salim M. Adib, Selim Gebran, Anthony Gebran, Walid Ammar |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2018-03-01
|
Series: | Journal of Global Oncology |
Online Access: | http://ascopubs.org/doi/10.1200/JGO.17.00179 |
Similar Items
-
Budget Impact of Treatment-Free Remission in Treating Chronic-Phase Philadelphia-Positive Chronic Myeloid Leukemia in Lebanon
by: Fadia Elias, et al.
Published: (2019-06-01) -
Addressing the COVID-19 emergency during the ongoing political and economic crisis in Fragile Lebanon: a call to action
by: Ludmila Lobkowicz, et al.
Published: (2021-09-01) -
Generating Stellar Spectra Using Neural Networks
by: Marwan Gebran
Published: (2024-01-01) -
Patterns and determinants of mammography screening in Lebanese women
by: Nadia Elias, et al.
Published: (2017-03-01) -
COVID-19 IN LEBANON: UPDATE, CHALLENGES AND LESSONS LEARNED
by: N. Melhem, et al.
Published: (2023-05-01)